Picture of Abionyx Pharma SA logo

ABNX Abionyx Pharma SA Balance Sheet

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Abionyx Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments11.58.339.157.934.05
Net Total Accounts Receivable
Net Total Receivables1.151.730.6173.932.75
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets12.810.110137.57
Net Property, Plant And Equipment0.0230.0930.1153.072.56
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets13.110.210.321.815.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities8.513.473.66.755.09
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities9.33.583.6611.28.65
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity3.846.676.6310.77.17
Total Liabilities & Shareholders' Equity13.110.210.321.815.8
Total Common Shares Outstanding